IL1B and gastric cancer: In Colombia, it has been observed that the presence of the 1082 (A/G) point mutation in the IL-10 gene (79%), together with another mutation in position 511 of the IL-1β gene (72%) and the Th1 immune response, increase the risk for gastric cancer in human populations [4].